Corruption in Pharmaceuticals – International Perspective 5 – Blog Post #498 by Asrar Qureshi
Corruption in Pharmaceuticals – International Perspective 5 – Blog Post #498 by Asrar Qureshi Dear Colleagues! This is Pharma Veterans Blog Post #498. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Continued from Previous…… This series is based on a report compiled by Jilian Clare Cohen1, Monique Mrazek2, and Loraine Hawkins3 for World Bank. Six decision points were identified where corruption could infiltrate. The first was manufacturing which was taken up in the last blog. Second is discussed below. Decision Point Two: Registration and Market Authorization 1950s saw the great tragedy of a large number of limbless children born to women who were taking the drug, thalidomide. The drug was introduced as a sedative and became a popular prescription rapidly. Soon...